Principal Financial Group Inc Pulmonx Corp Transaction History

Principal Financial Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$8.71 - $14.65 $958 - $1,611	-110 Reduced 1.01%	10,738 $99,000
Q4 2023 Feb 07, 2024	BUY	$7.89 - $13.14 $528 - $880	67 Added 0.62%	10,848 $138,000
Q3 2023 Nov 02, 2023	SELL	$9.88 - $14.0 $4,623 - $6,552	-468 Reduced 4.16%	10,781 $111,000
Q2 2023 Aug 07, 2023	BUY	$10.78 - $13.65 $121,264 - $153,548	11,249 New	11,249 $147,000
Q4 2022 Feb 09, 2023	BUY	$4.92 - $17.35 $51,414 - $181,307	10,450 New	10,450 $88,000
Q1 2022 May 09, 2022	SELL	$21.13 - $35.65 $348,349 - $587,725	-16,486 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$29.72 - $45.1 $279,189 - $423,669	9,394 Added 132.46%	16,486 $529,000
Q3 2021 Nov 09, 2021	SELL	$35.98 - $44.48 $41,269 - $51,018	-1,147 Reduced 13.92%	7,092 $255,000
Q2 2021 Aug 10, 2021	BUY	$37.61 - $48.0 $309,868 - $395,472	8,239 New	8,239 $363,000

123

31M

300

204K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.